Regulus Therapeutics Inc
General ticker "RGLS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $103.9M
Regulus Therapeutics Inc follows the US Stock Market performance with the rate: 6.3%.
Estimated limits based on current volatility of 3.0%: low 1.49$, high 1.58$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.85$, 2.32$]
- 2024-12-30 to 2025-12-30 estimated range: [0.97$, 2.49$]
Financial Metrics affecting the RGLS estimates:
- Negative: Non-GAAP EPS, $ of -1.59 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -51.34 <= 2.35
- Negative: negative Net income
- Positive: Investing cash flow per share, $ of 0.76 > -0.12
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
- Positive: Inventory ratio change, % of 0 <= 1.08
Short-term RGLS quotes
Long-term RGLS plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $27.82MM | $28.24MM | $31.11MM |
| Operating Income | $-27.82MM | $-28.24MM | $-31.11MM |
| Non-Operating Income | $0.01MM | $-0.08MM | $1.07MM |
| Interest Expense | $0.85MM | $0.69MM | $0.60MM |
| R&D Expense | $17.79MM | $18.41MM | $21.15MM |
| Income(Loss) | $-27.81MM | $-28.32MM | $-30.04MM |
| Taxes | $0.00MM | $0.00MM | $0.00MM |
| Profit(Loss) | $-27.81MM | $-28.32MM | $-30.04MM |
| Stockholders Equity | $54.96MM | $33.29MM | $21.19MM |
| Inventory | $0.00MM | $0.00MM | $3.01MM |
| Assets | $68.45MM | $46.72MM | $30.75MM |
| Operating Cash Flow | $-24.13MM | $-25.53MM | $-26.77MM |
| Capital expenditure | $0.25MM | $0.36MM | $0.61MM |
| Investing Cash Flow | $-0.25MM | $-15.12MM | $14.49MM |
| Financing Cash Flow | $53.74MM | $4.49MM | $11.82MM |
| Earnings Per Share* | $-3.24 | $-1.86 | $-1.58 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.